SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0*
暂无分享,去创建一个
Michael G. Stabin | Rebecca Sajdak | George Segall | Gary T. Smith | D. Delbeke | E. Even-Sapir | M. Stabin | Einat Even-Sapir | Dominique Delbeke | Joanna Fair | G. Segall | J. Fair | R. Sajdak
[1] J. Devogelaer,et al. 18F-Fluoride PET for Monitoring Therapeutic Response in Paget’s Disease of Bone , 2005 .
[2] ICRP. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. , 2008, Annals of the ICRP.
[3] W. Brenner,et al. Assessment of the metabolic activity of bone grafts with 18F-fluoride PET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Jeannette M. Perez-Rossello,et al. Skeletal trauma in child abuse: detection with 18F-NaF PET. , 2010, Radiology.
[5] E. Mittra,et al. Novel Strategy for a Cocktail 18F-Fluoride and 18F-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase Study , 2009, Journal of Nuclear Medicine.
[6] T. Brunkhorst,et al. Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[7] M. Anders,et al. F-18 Fluoride Positron Emission Tomography of the Hip for Osteonecrosis , 2008, Clinical orthopaedics and related research.
[8] H. Schirrmeister. Detection of Bone Metastases in Breast Cancer by Positron Emission Tomography. , 2006, PET clinics.
[9] S. Wientroub,et al. Back Pain in Adolescents: Assessment With Integrated 18F-Fluoride Positron-emission Tomography-Computed Tomography , 2007, Journal of pediatric orthopedics.
[10] M. Zanetti,et al. Therapeutic impact of [18F]fluoride positron-emission tomography/computed tomography on patients with unclear foot pain , 2010, Skeletal Radiology.
[11] Eyal Mishani,et al. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] S. Ben-Haim,et al. Breast cancer: role of SPECT and PET in imaging bone metastases. , 2009, Seminars in nuclear medicine.
[13] H. Schirrmeister,et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] U. Metser,et al. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] D. B. Tuinzing,et al. No signs of metabolic hyperactivity in patients with unilateral condylar hyperactivity: an in vivo positron emission tomography study. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[16] I. Fogelman,et al. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. , 2006, Seminars in nuclear medicine.
[17] S. Basu,et al. Combined 18F-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future? , 2010, Journal of Nuclear Medicine.
[18] S Ted Treves,et al. Early Experience With Fluorine-18 Sodium Fluoride Bone PET in Young Patients With Back Pain , 2007, Journal of pediatric orthopedics.
[19] Christian Schumann,et al. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[20] A. D. Van den Abbeele,et al. Clinical, Radiographic, and Biochemical Characterization of Multiple Myeloma Patients with Osteonecrosis of the Jaw , 2008, Clinical Cancer Research.
[21] T. Schulz,et al. Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[22] T. Schilling,et al. Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] M. Lubberink,et al. Bone Metabolism after Total Hip Revision Surgery with Impacted Grafting: Evaluation using H215O and [18F]fluoride PET; A Pilot Study , 2008, Molecular Imaging and Biology.
[24] L. Drubach,et al. Fluorine-18 NaF PET imaging of child abuse , 2008, Pediatric Radiology.
[25] H. Schirrmeister,et al. Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography. , 2001, Thyroid : official journal of the American Thyroid Association.
[26] Winfried Brenner,et al. PET imaging of osteosarcoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] H. Schirrmeister,et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] S Ted Treves,et al. Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer* , 2007, Journal of Nuclear Medicine.
[29] Eyal Mishani,et al. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography. , 2007, Seminars in nuclear medicine.
[30] J. Carrasquillo,et al. Alendronate does not interfere with 99mTc-methylene diphosphonate bone scanning. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] E. Nitzsche,et al. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? , 1998, Radiology.
[32] J. Valentin,et al. Radiation dose to patients from radiopharmaceuticals: (Addendum 2 to ICRP Publication 53) ICRP Publication 80 Approved by the Commission in September 1997 , 1998, Annals of the ICRP.
[33] P. Waldenberger,et al. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET–CT: a comparative study , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[34] R. Takeuchi,et al. Evaluation of lesion in a spontaneous osteonecrosis of the knee using 18F-fluoride positron emission tomography , 2008, Knee Surgery, Sports Traumatology, Arthroscopy.
[35] W. Oyen,et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[36] R. Sparks,et al. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. , 1997, Health physics.
[37] Hisatoshi Baba,et al. Effects of Alendronate on Bone Metabolism in Glucocorticoid-Induced Osteoporosis Measured by 18F-Fluoride PET: A Prospective Study , 2009, Journal of Nuclear Medicine.
[38] J. Sörensen,et al. Bone healing of severe acetabular defects after revision arthroplasty , 2009, Acta orthopaedica.
[39] W. Wong,et al. [18F]-fluoride positron emission tomography for imaging condylar hyperplasia. , 2009, The British journal of oral & maxillofacial surgery.
[40] Mohsen Beheshti,et al. Prostate cancer: role of SPECT and PET in imaging bone metastases. , 2009, Seminars in nuclear medicine.
[41] G. Cook,et al. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases. , 2009, Seminars in nuclear medicine.